Somato® (Phytomelatonin) Versus Synthetic Melatonin and Placebo on Sleep Quality

Inclusion Criteria: * Device Compliance: Willingness to consistently wear an Oura Ring Gen3 and maintain an active membership throughout the study duration. * Baseline Sleep Score: A baseline Oura sleep score of less than 75, indicating sub-optimal sleep quality. * Oura Ring Usage History: Demonstrated at least 80% adherence to Oura Ring use during the 30 days prior to enrollment. * Health and Supplement Stability: No significant changes in dietary supplement use or medical history within the past 30 days, to ensure stability in baseline physiological and health conditions. Exclusion Criteria: * Current or recent use (within the past 30 days) of any sleep-promoting dietary supplement. * Current or recent use (within the past 30 days) of any sleep-promoting medications, whether prescription or over-the-counter. * Pregnant or breastfeeding women will be excluded from the study. * Substance Use Disorder: Individuals with a history of drug or alcohol dependency who have not maintained sobriety for a minimum of the past 12 months. * Severe Medical Conditions: Presence of severe or unstable medical conditions that may interfere with study participation or outcomes. * Use of Mood-Affecting Medications: Use of any medications known to significantly influence mood, circadian rhythms, or melatonin pathways. * Sensitivity to Nightshades: Known sensitivity or allergy to nightshade plants, including tomatoes, due to the nature of the study intervention.